These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 19667303

  • 1. Thiazolidinediones and fractures in men and women.
    Dormuth CR, Carney G, Carleton B, Bassett K, Wright JM.
    Arch Intern Med; 2009 Aug 10; 169(15):1395-402. PubMed ID: 19667303
    [Abstract] [Full Text] [Related]

  • 2. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N, McAfee AT, Koro C, Landon J, Arnold Chan K.
    Clin Ther; 2009 Nov 10; 31(11):2665-77. PubMed ID: 20110009
    [Abstract] [Full Text] [Related]

  • 3. Distal upper and lower limb fractures associated with thiazolidinedione use.
    Jones SG, Momin SR, Good MW, Shea TK, Patric K.
    Am J Manag Care; 2009 Aug 10; 15(8):491-6. PubMed ID: 19670952
    [Abstract] [Full Text] [Related]

  • 4. Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).
    Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G, Diabetes Outcome Progression Trial (ADOPT) Study Group.
    Diabetes Care; 2008 May 10; 31(5):845-51. PubMed ID: 18223031
    [Abstract] [Full Text] [Related]

  • 5. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM.
    Pharmacoepidemiol Drug Saf; 2007 Jul 10; 16(7):711-25. PubMed ID: 17551989
    [Abstract] [Full Text] [Related]

  • 6. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.
    Clin Ther; 2004 Sep 10; 26(9):1400-10. PubMed ID: 15531002
    [Abstract] [Full Text] [Related]

  • 7. Use of thiazolidinediones and fracture risk.
    Meier C, Kraenzlin ME, Bodmer M, Jick SS, Jick H, Meier CR.
    Arch Intern Med; 2008 Apr 28; 168(8):820-5. PubMed ID: 18443256
    [Abstract] [Full Text] [Related]

  • 8. Medical therapy for diabetes is associated with increased use of lower endoscopy.
    Lewis JD, Capra AM, Achacoso NS, Ferrara A, Levin TR, Quesenberry CP, Habel LA.
    Pharmacoepidemiol Drug Saf; 2007 Nov 28; 16(11):1195-202. PubMed ID: 17603822
    [Abstract] [Full Text] [Related]

  • 9. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS.
    Acta Diabetol; 2009 Jun 28; 46(2):145-54. PubMed ID: 19194648
    [Abstract] [Full Text] [Related]

  • 10. The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.
    Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger JD.
    Pharmacoepidemiol Drug Saf; 2007 May 28; 16(5):504-12. PubMed ID: 17245800
    [Abstract] [Full Text] [Related]

  • 11. Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.
    Hartung DM, Touchette DR, Bultemeier NC, Haxby DG.
    Pharmacotherapy; 2005 Oct 28; 25(10):1329-36. PubMed ID: 16185176
    [Abstract] [Full Text] [Related]

  • 12. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
    Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM.
    Circulation; 2005 Feb 08; 111(5):583-90. PubMed ID: 15699279
    [Abstract] [Full Text] [Related]

  • 13. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
    Aubert RE, Herrera V, Chen W, Haffner SM, Pendergrass M.
    Diabetes Obes Metab; 2010 Aug 08; 12(8):716-21. PubMed ID: 20590749
    [Abstract] [Full Text] [Related]

  • 14. Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes.
    Peters Harmel AL, Kendall DM, Buse JB, Boyle PJ, Marchetti A, Lau H.
    Curr Med Res Opin; 2004 Aug 08; 20(2):215-23. PubMed ID: 15006017
    [Abstract] [Full Text] [Related]

  • 15. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC, Chen WL, Kao TW, Chang YW, Loh CH, Chou CC.
    Clin Ther; 2011 Dec 08; 33(12):1904-13. PubMed ID: 22118894
    [Abstract] [Full Text] [Related]

  • 16. A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes.
    Gerrits CM, Bhattacharya M, Manthena S, Baran R, Perez A, Kupfer S.
    Pharmacoepidemiol Drug Saf; 2007 Oct 08; 16(10):1065-71. PubMed ID: 17674425
    [Abstract] [Full Text] [Related]

  • 17. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan 08; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 18. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
    Pinelli NR, Cha R, Brown MB, Jaber LA.
    Ann Pharmacother; 2008 Nov 08; 42(11):1541-51. PubMed ID: 18957626
    [Abstract] [Full Text] [Related]

  • 19. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications.
    Stockl KM, Le L, Zhang S, Harada AS.
    Pharmacoepidemiol Drug Saf; 2009 Feb 08; 18(2):166-74. PubMed ID: 19109802
    [Abstract] [Full Text] [Related]

  • 20. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.
    Idris I, Warren G, Donnelly R.
    Arch Intern Med; 2012 Jul 09; 172(13):1005-11. PubMed ID: 22688528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.